companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

LIBRESCONSEIL

PARIS 75017 - FR-France

Company Name:
Corporate Name:
LIBRESCONSEIL
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 41 rue Dulong,PARIS 75017 - FR,,France 
ZIP Code:
Postal Code:
 
Telephone Number:  
Fax Number:  
Website:
 
Email:
 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
LIBRAIRIE ULYSSE
LIBRAIRIES TECHNIQUES LITEC
LIBRES CONSEIL
Next company profile:
LIBRESCONSEIL
LIBRISZONE S.A
LICENCES










Company News:
  • Acquired Hemophilia Treatment Management - Medscape
    Recombinant antihemophilic factor, porcine sequence Historically, porcine factor VIII has provided a good effect A porcine sequence recombinant FVIII (rpFVIII; Obizur) was approved by the US Food and Drug Administration (FDA) in 2014 for treatment of bleeding episodes in adults with acquired hemophilia
  • Hemophilia Therapies - Rare Disease Advisor
    Koāte ® (antihemophilic factor [human]), also known as Koāte-DVI, is a human plasma-derived FVIII indicated for the treatment and prevention of bleeding episodes in patients with hemophilia A Initially approved in the US in 1974, the processing methods have been updated over the years to make the product safer from viral contamination
  • AHF (Antihemophilic Factor): Uses Side Effects
    AHF (antihemophilic factor) is a medication that prevents or manages bleeding if you have hemophilia A This condition keeps your blood from clotting as it should so you bleed more than expected A healthcare provider will usually give you this injection in a hospital or clinic setting




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer